Sigma Healthcare (SIG) - FY25 result analysis

Injecting leverage into sales

Published: 10 September 2025

Sigma reported FY25 network sales growth for Chemist Warehouse of 14% and EBIT at $903 million, up 47%. The company reported a continuation of double-digit like-for-like sales growth with a lift in profit margins for the underlying Chemist Warehouse business. We forecast EBIT growth of 22% in FY26e ahead of revenue growth of 15%. Margins will be helped by penetration of Wagner private label, operating leverage from strong comp sales and the increasing synergies over the next four years.

Unlock the full report, including detailed analysis, charts, and the downloadable presentation. to continue, or Sign Up to get access to all reports.

Not already a member?
Join now to get all the latest reports in full and stay informed.

Get started